Skip to main content
. 2021 Apr 8;12(5):798–804. doi: 10.1021/acsmedchemlett.1c00065

Table 1. COX-1 and COX-2 Enzyme Inhibition Data of N-Aryl 5-Amino-pyrazoles 12–18a.

compd R1 COX-1 IC50 (μM) COX-2 IC50 (μM) COX-1 SI OVCAR-3 IC50 (μM) ClogP TPSA (Å2)
12 H 8.5 >100 >11 5.8 2.89 50.85
13 F 1.6 >100 >61 5.0 3.12 56.99
14 Cl 3.4 >100 >30 20.5 3.69 50.85
15 OCH3 1.2 30.6 26 5.4 2.88 60.08
16 CH(CH3)2 2.6 >100 >38 1.1 3.37 50.85
17 COOH 0.10 >100 >1000 0.07 2.74 88.15
18 COOCH3 0.19 >100 526 0.09 3.02 83.29
SC560   0.01 55.6 5560 0.008 6.18 24.83
celecoxib   >100 0.09 >1111 80.9 4.37 75.76
a

Assays were conducted as described in the COX Inhibition Assay section of the Supporting Information. IC50, half-maximal inhibitory concentration; SI, in vitro COX-1 selectivity index: [(COX-1 IC50)/(COX-2 IC50)]; data are the mean of three determinations. The ClogP and TPSA value were calculated using ChemDraw 16.0.